Cargando…
Alternate Donor Transplantation
There is a significant need for alternative donors other than full-matched related or unrelated donors for allogeneic hematopoietic stem cell transplantation, especially in the Asia Pacific, where donor registries are smaller, and ethnicities are far more diverse. Both umbilical cord blood (UCB) and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200364/ https://www.ncbi.nlm.nih.gov/pubmed/37220609 http://dx.doi.org/10.31547/bct-2022-012 |
_version_ | 1785045115725676544 |
---|---|
author | Hwang, William YK Kongtim, Piyanuch Majhail, Navneet S Yao, Ming |
author_facet | Hwang, William YK Kongtim, Piyanuch Majhail, Navneet S Yao, Ming |
author_sort | Hwang, William YK |
collection | PubMed |
description | There is a significant need for alternative donors other than full-matched related or unrelated donors for allogeneic hematopoietic stem cell transplantation, especially in the Asia Pacific, where donor registries are smaller, and ethnicities are far more diverse. Both umbilical cord blood (UCB) and haploidentical transplantation can be carried out despite significant human leukocyte antigen (HLA) mismatches between patients and donors and help to meet this need. There are advantages and disadvantages to UCB and haploidentical transplantation, though enhancements in technology continue to improve outcomes in both. Donor selection for these cell sources is dependent on the presence of donor specific anti-HLA antibodies in the recipient's serum, degree and characteristics of donor-recipient HLA mismatches, ABO compatibility. Specific to haploidentical transplantation, additional factors like donor age, sex, donor-recipient CMV serology as well as NK cell alloreactivity are also important. |
format | Online Article Text |
id | pubmed-10200364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Asia-Pacific Blood and Marrow Transplantation Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-102003642023-05-22 Alternate Donor Transplantation Hwang, William YK Kongtim, Piyanuch Majhail, Navneet S Yao, Ming Blood Cell Ther State of the Art There is a significant need for alternative donors other than full-matched related or unrelated donors for allogeneic hematopoietic stem cell transplantation, especially in the Asia Pacific, where donor registries are smaller, and ethnicities are far more diverse. Both umbilical cord blood (UCB) and haploidentical transplantation can be carried out despite significant human leukocyte antigen (HLA) mismatches between patients and donors and help to meet this need. There are advantages and disadvantages to UCB and haploidentical transplantation, though enhancements in technology continue to improve outcomes in both. Donor selection for these cell sources is dependent on the presence of donor specific anti-HLA antibodies in the recipient's serum, degree and characteristics of donor-recipient HLA mismatches, ABO compatibility. Specific to haploidentical transplantation, additional factors like donor age, sex, donor-recipient CMV serology as well as NK cell alloreactivity are also important. Asia-Pacific Blood and Marrow Transplantation Group 2022-12-23 /pmc/articles/PMC10200364/ /pubmed/37220609 http://dx.doi.org/10.31547/bct-2022-012 Text en Copyright Ⓒ2022 Asia-Pacific Blood and Marrow Transplantation Group (APBMT). https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/). |
spellingShingle | State of the Art Hwang, William YK Kongtim, Piyanuch Majhail, Navneet S Yao, Ming Alternate Donor Transplantation |
title | Alternate Donor Transplantation |
title_full | Alternate Donor Transplantation |
title_fullStr | Alternate Donor Transplantation |
title_full_unstemmed | Alternate Donor Transplantation |
title_short | Alternate Donor Transplantation |
title_sort | alternate donor transplantation |
topic | State of the Art |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200364/ https://www.ncbi.nlm.nih.gov/pubmed/37220609 http://dx.doi.org/10.31547/bct-2022-012 |
work_keys_str_mv | AT hwangwilliamyk alternatedonortransplantation AT kongtimpiyanuch alternatedonortransplantation AT majhailnavneets alternatedonortransplantation AT yaoming alternatedonortransplantation |